Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Reaction Biology

Reaction Biology?uq=XnI5dm0O
2001 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Grant LATEST DEAL TYPE
$513K LATEST DEAL AMOUNT
4 INVESTORS
Description

Provider of drug profiling services designed to specialize in kinase and epigenetic drug discovery. The company's drug profiling services offers a wide range of services, including robust assay technologies for kinase and epigenetic biochemical and cell-based high throughput screening (HTS) and selectivity compound profiling to the biotech and pharmaceutical companies.

Formerly Known As
Morewood Molecular Sciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 1 Great Valley Parkway
  • Suite 2
  • Malvern, PA 19355
  • United States

+1 (877) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Reaction Biology’s full profile, request a free trial.

Reaction Biology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 01-Jul-2015 $513K Completed Generating Revenue
9. Grant 07-Jul-2014 00000 Completed Generating Revenue
8. Grant 01-Jan-2011 00.00 Completed Generating Revenue
7. Grant 11-Aug-2010 00.00 Completed Generating Revenue
6. Grant 01-Jan-2009 00000 Completed Generating Revenue
5. Grant 01-Jan-2007 00000 Completed Generating Revenue
4. Grant 20-Jun-2006 00000 Completed Generating Revenue
3. Grant 09-Aug-2005 00000 Completed Startup
2. Grant 01-Jan-2002 $200K Completed Startup
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Reaction Biology Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Center For Advancing Translational Sciences Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
LaunchCyte Venture Capital Minority 000 0000 000000 0

Reaction Biology Executive Team (3)

Name Title Board
Seat
Contact
Info
Matthew Oristano Chief Executive Officer, Board Member & President
Robert Hartman Chief Information Officer
Haiching Ma Ph.D Chief Science Officer & Board Member

Reaction Biology Board Members (4)

Name Representing Role Since Contact
Info
Haiching Ma Ph.D Reaction Biology Chief Science Officer & Board Member 000 0000
Jonathan Kaufman Ph.D Self Board Member 000 0000
Michael Kramer Self Board Member 000 0000
Thomas Petzinger Jr. LaunchCyte Board Member 000 0000